CAS 57773-63-4 Triptorelin Acetate 2mg/Vial Raises Testosterone Levels For Weight Loss

Details

Product Name: Triptorelin
CAS: 57773-63-4
MF: C64H82N18O13
MW: 1311.45

COA:

Usage promoting ovulation

Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.
Triptorelin is used for:
Treating symptoms of advanced prostate cancer. It may be used for other conditions as determined by your doctor.
Triptorelin is a synthetic analogue of gonadotropin-releasing hormone (GnRH) agonist. It works by decreasing the production of certain hormones, which reduces testosterone levels in the body.

Triptorelin usage:

Triptorelin is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using triptorelin at home, a health care provider will teach you how to use it. Be sure you understand how to use triptorelin. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.
Triptorelin is injected into the muscle.
Rotate the injection site. Do not inject into an area of skin that is red, hard, or bruised, or has scars or stretch marks.
Do not use triptorelin if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.
Keep this product, as well as syringes and needles, out of the reach of children and away from pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use.

Applications:

Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl (Ipsen) and Diphereline and Gonapeptyl . In the United States, it is sold by Watson as Trelstar.In Iran Triptorelin is marketed under the brand name Variopeptyl (Varian Darou Pajooh). In India, Dr. Reddy's Laboratories has launched recently Triptorelin under the brand name "Pamorelin LA". In men a reduction of serum levels into the range normally seen after surgical castration occurs approximately two to four weeks after initiation of therapy.